Placeholder Banner

BIO Response to RFI: National Biotechnology & Biomanufacturing Initiative

January 23, 2023

BIO's response to the Office of Science & Technology Policy's Request for Information concerning the National Biotechnology & Biomanufacturing Initiative

Download Full Comments Below
BIO Response to RFI: National Biotechnology & Manufacturing Initiative

BIO's response to the Office of Science & Technology Policy's Request for Information concerning the National Biotechnology and Biomanufacturing Initiative

Discover More
The Biotechnology Innovation Organization appreciates the opportunity to comment on the Center for Medicare and Medicaid Services’ Information Collection Request on the Part C and Part D Medicare Prescription Payment Plan Model Documents.
In response to the 340B Request for Information issued by the Senate 340B Bipartisan Working Group, BIO submits detailed comments.
We are writing to express our strong support for the bipartisan Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act). The legislation, which was introduced by Reps. John Joyce (R-PA) and Wiley Nickel (D-NC) in September,1 corrects a…